Get access

The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens


  • On behalf of: G. M. Th. Schreuder, C. K. Hurley, S. G. E. Marsh, M. Lau, M. Maiers, World Marrow Donor Association Quality Assurance and IT Working Groups; G. M. Th. Schreuder, C. K. Hurley, S. G. E. Marsh, WHO Nomenclature Committee for Factors of the HLA system; G. M. Th. Schreuder, M. Fernandez-Vina, M. Maiers, 13th International Histocompatibility Workshop Serology Component; M. Lau, International Cell Exchange, UCLA; C. K. Hurley, H. J. Noreen, M. Setterholm, M. Maiers, US National Marrow Donor Program.

G.M.Th. Schreuder, PhD, Department of Immunohematology and Blood Transfusion, E3-Q, Leiden University Medical Center, PO Box 9600, NL-2300 RC Leiden, the Netherlands. E-mail:


This report presents serological equivalents of HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5 and -DQB1 alleles. The dictionary is an update of that published in 2001. The data summarize equivalents obtained by the World Health Organization Nomenclature Committee for Factors of the HLA System, the International Cell Exchange (UCLA), the National Marrow Donor Program (NMDP), recent publications and individual laboratories. This latest update of the dictionary is enhanced by the inclusion of results from studies performed during the 13th International Histocompatibility Workshop and from neural network analyses. A summary of the data as recommended serological equivalents is presented as expert assigned types. The tables include remarks for alleles, which are or may be expressed as antigens with serological reaction patterns that differ from the well-established HLA specificities. The equivalents provided will be useful in guiding searches for unrelated haematopoietic stem cell donors in which patients and/or potential donors are typed by either serology or DNA-based methods. The serological DNA equivalent dictionary will also aid in typing and matching procedures for organ transplant programmes whose waiting lists of potential donors and recipients comprise mixtures of serological and DNA-based typings. The tables with HLA equivalents and a questionnaire for submission of serological reaction patterns for poorly identified allelic products will be made available through the WMDA web page ( and, in the near future, also in a searchable form on the IMGT/HLA database.

Get access to the full text of this article